CX26 promotes pancreatic cancer progression by competitively inhibiting interaction of c-Myc with PSMD2 and enhancing c-Myc stability
Abstract Background Pancreatic cancer (PC) is highly aggressive and fatal and has dismal prognostic outcomes, primarily due to its late-stage diagnosis and limited effective treatments. The molecular mechanisms triggering PC progression are largely unclear. This study investigated how CX26 contribut...
Saved in:
| Main Authors: | Cheng He, Chuanyu Tang, Jie Guo, Xiangyi Yin, Qing Zhu, Chihua Fang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-025-06983-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
JS-K induces ferroptosis in renal carcinoma cells by regulating the c-Myc-GSTP1 Axis
by: Yuwan Zhao, et al.
Published: (2025-05-01) -
Innovative evaluation of selinexor and JQ1 synergy in leukemia therapy via C-MYC inhibition
by: Pei-Hong Wang, et al.
Published: (2025-05-01) -
PAK4 phosphorylates and stabilizes MYC to promote acute myeloid leukemia
by: Ting Xie, et al.
Published: (2025-10-01) -
PSMD14 Stabilizes SLC7A11 to Ameliorate Glucocorticoid‐Induced Osteoporosis by Suppressing Osteocyte Ferroptosis
by: Yifeng Shi, et al.
Published: (2025-08-01) -
Differentiated approach in the treatment of diffuse large B-cell lymphoma according to c-MYC and BCL2 status
by: R. K. Karakulov, et al.
Published: (2022-01-01)